Innovating Works

SIXFOLD

Desconocido
DESTINATION: AI enabled RNA nanotechnology DElivery SysTem for INformATION transfer into cells. SIXFOLD BIOSCIENCE LTD tramitó un H2020: H2020-FETOPEN-2018-2020 By combining the interdisciplinary fields of AI/machine learning with RNA nanotechnology, biochemistry and advanced imaging methods, DESTINA...
2021-01-20 - 2025-03-31 | Financiado
OLIGOMED: Oligonucleotides for Medical Applications SIXFOLD BIOSCIENCE LTD participó en un H2020: H2020-MSCA-ITN-2020 The use of synthetic oligonucleotides (ONs, short DNA or RNA strands) in the treatment of genetic diseases is a rapidly growing field, and t...
2020-08-13 - 2025-06-30 | Financiado
NanoRNA_PC: Engineering the protein corona on RNA nanoparticles for improved nucleic acids based therapies deliv... SIXFOLD BIOSCIENCE LTD tramitó un H2020: H2020-MSCA-IF-2019 In the past three decades, nanomedicine has emerged as a promising strategy in cancer treatment and has led to numerous proposed drug delive...
2020-03-27 - 2022-05-25 | Financiado
mRNA NanoDeli: Application of RNA nanotechnology for delivery of mRNA therapeutics SIXFOLD BIOSCIENCE LTD tramitó un H2020: H2020-INNOSUP-2018-2020 Sixfold Bioscience is a biotechnology company that conducts preclinical research and development on its patented Programmable Oligonucleotid...
2019-08-30 - 2021-04-09 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.